Grifols GRFS
NASDAQ GRFS
$7.31 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Grifols (GRFS) Deferred Taxes (2009 - 2010)

Updated

Grifols' Deferred Taxes came in at $21.11 million for the quarter ended Dec 31, 2010, up 61.9% from $13.04 million a year earlier.

Analysis

Grifols (GRFS) Deferred Taxes (2009 - 2010) Analysis & Trends

For the year ended Dec 31, 2010, Grifols' Deferred Taxes was $20.63 million, up 67.4% from the prior year.

  • Going back by year, Deferred Taxes was $12.32 million in the year ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -479.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -195.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -587.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Grifols 4.97 Bn 4.59 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 21.11 Mn
Dec 31, 2009 13.04 Mn
API Access

Grifols Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=GRFS&period=max&api_key=YOUR_API_KEY